Copyright
©The Author(s) 2021.
World J Hepatol. Oct 27, 2021; 13(10): 1394-1404
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1394
Published online Oct 27, 2021. doi: 10.4254/wjh.v13.i10.1394
Examined parameter, baseline values | Patients alive/not transplanted at the end of the follow-up, n = 54 | Patients transplanted or dead, n = 9 | P value |
Age in yr1 | 59 ± 15 | 66 ± 14 | 0.238 |
Liver-specific treatment, Y/N | 28/26 | 4/5 | 0.474 |
CTP score | 5.9 ± 1.0 | 7.4 ± 1.4 | < 0.001 |
MELD score | 11.3 ± 3.0 | 11.7 ± 3.6 | 0.772 |
High-risk varices, Y/N | 19/54 | 5/9 | 0.241 |
Platelet count as × 109/L | 120 ± 52 | 109 ± 40 | 0.602 |
Albumin in g/dL | 3.87 ± 0.62 | 3.20 ± 0.62 | 0.010 |
Spleen diameter in cm | 13.7 ± 2.8 | 15.2 ± 2.5 | 0.154 |
Portal diameter in cm | 1.27 ± 0.21 | 1.55 ± 0.25 | 0.002 |
Liver stiffness in kPa | 22.5 ± 9.2 | 27.9 ± 10.3 | 0.127 |
Spleen stiffness in kPa | 35.0 ± 8.8 | 37.9 ± 6.9 | 0.383 |
Serum zonulin levels in ng/mL | 3.70 ± 1.36 | 3.17 ± 1.21 | 0.300 |
- Citation: Voulgaris TA, Karagiannakis D, Hadziyannis E, Manolakopoulos S, Karamanolis GP, Papatheodoridis G, Vlachogiannakos J. Serum zonulin levels in patients with liver cirrhosis: Prognostic implications. World J Hepatol 2021; 13(10): 1394-1404
- URL: https://www.wjgnet.com/1948-5182/full/v13/i10/1394.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i10.1394